SpectraGenetics

SpectraGenetics, LLC applies its patented and proprietary processes to produce and market genetically encoded reporter tagged genes.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Penn, PA, USA
  • Currency USD
  • Founded February 2003
  • Employees 7
  • Website spectragenetics.com

Company Summary

SpectraGenetics, LLC produces genetically encoded reporter tagged genes that are used for drug discovery and development. Our full length reporter genes are primarily used for target identification and validation whereas our FAP-tagged genes are used for high throughput screening of leads. Our customers include researchers involved in drug discovery at academic institutes, government laboratories and leading pharmaceutical companies.

Team

  • Reid Asbury
    CEO

    G. Reid Asbury, Ph.D., CEO, has more than ten years of experience in the pharmaceutical industry across sales, marketing, and business development. Previous employers include Amersham Pharmacia Biotech, General Electric and Protea Biosciences.

  • Jonathan W. Jarvik
    Founding Scientist

    Jonathan Jarvik, Ph.D., Co-Founder is a luminary in molecular biology and the chief researcher. He holds 10 patents, over 100 peer reviewed journals, and has started two companies

  • Chaofu Shi
    Director of Research and Development

    Dr. Shi has 15 years of academic and industrial experience in molecular biology as well as an MBA in finance and marketing. Dr. Shi leads the Company’s gene tagging program.

  • G. Reid Asbury

Advisors

  • David Smith
    Lawyer
    Unconfirmed
    Sharon Weisberg
    Accountant
    Unconfirmed

Previous Investors

  • Idea Foundry
    Unconfirmed
    Innovation Works
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free